semaglutide
63% Greater Weight Loss: Tirzepatide Outperforms Semaglutide in MC4R
Tirzepatide achieved 63% greater weight loss than semaglutide in MC4R-deficient animal models, according to a recent meta-analysis. This finding highlights a potential advantage for tirzepatide when treating obesity linked to melanocortin-4 receptor deficiency. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult